Monograph
A03AA04 - Mebeverine |
Propably not porphyrinogenic |
PNP |
Rationale
Mebeverine is not listed as a CYP-inducer or inhibitor, and is not known to interfere with the CYP-metabolism of other drugs. There are no indications of porphyrinogenic effects connected with the pharmacodynamic properties of the drug.
Some preparations may include the laxative ispanhula, which also is classified PNP.
Chemical description
Mebeverine is the veratric acid ester of a substituted ethylamphetamine derivative.
Therapeutic characteristics
Mebeverine is an antispasmodic used in conditions such as irritable bowel syndrome. It is administered orally.
Metabolism and pharmacokinetics
Mebeverine is metabolised by hydrolysis to veratric acid and mebeverine alcohol. Mebeverine alcohol may go through further breakdown and conjugation before it is renally excreted.
Preclinical data
Moore and Hift claims porphyrinogenisity is shown in in vitro studies, but gives no references.
IPNet drug reports
Uneventful use reported in 2 patients with acute porphyria.
References
# | Citation details | PMID |
---|---|---|
* | Scientific articles | |
1. | Investigative implications of the instability and metabolism of mebeverine.
Elliott S, Burgess V. J Anal Toxicol. 2006 Mar;30(2):91-7. |
16620538 |
2. | Drugs in the acute porphyrias - toxicogenetic diseases. Cell Mol Biol (Noisy-le-grand). 1997 Feb;43(1):89-94.
Moore MR, Hift RJ. |
9074793 |
* | Drug reference publications | |
3. | Sweetman SC, editor. Martindale: The complete drug reference. Mebeverine. Pharmaceutical Press 2009.
|
|
* | Summary of Product Characteristics | |
4. | The electronic Medicines Compendium (emc). Summary of Product Characteristics (SPC). Colofac MR.
|
Similar drugs
Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia).
Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway).
What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names
are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Netherlands
Duspatal · Duspatal 135 mg, omhulde tabletten · Duspatal Retard 200 mg, capsules met gereguleerde afgifte · Duspatal Retard 200 mg, harde capsules met gereguleerde afgifte · Mebeverine · Mebeverine HCl Aristo 200 mg harde capsules met gereguleerde afgifte · Mebeverine HCl Aurobindo Retard 200 mg, harde capsules met gereguleerde afgifte · Mebeverine HCl retard 200 mg, capsules met gereguleerde afgifteBelgium
Duspatalin · Duspatalin 135 mg compr. enr. · Duspatalin Retard 200 mg (PI Pharma) gél. lib. prol. · Duspatalin Retard 200 mg gél. lib. prol. · Mebeverine · Mebeverine AB 200 mg gél. lib. modif. · Mebeverine EG 135 mg compr. pellic.United Kingdom
Aurobeverine · Aurobeverine MR 200mg capsules · Boots IBS Relief · Boots IBS Relief 135mg tablets · Colofac · Colofac 135mg tablets · Colofac 50mg/5ml liquid · Colofac 100 · Colofac 100 tablets · Colofac IBS · Colofac IBS 135mg tablets · Colofac MR · Colofac MR 200mg capsules · Equilon · Equilon 135mg tablets · Mebeverine · Mebeverine 135mg oral powder sachets · Mebeverine 135mg tablets · Mebeverine 150mg/5ml oral suspension · Mebeverine 200mg modified-release capsules · Mebeverine 50mg/5ml oral suspension · Mebeverine 50mg/5ml oral suspension sugar freeDenmark
Duspatalin · Duspatalin Retard · Mebeverinhydrochlorid · Mebeverinhydrochlorid "Aristo"Norway
Duspatal · Duspatalin RetardPoland
Auroverin MR · Duspatalin · Duspatalin Gastro · Duspatalin retard · MebelinLuxembourg
DUSPATALIN · DUSPATALIN RETARDIceland
Duspatalin · Duspatalin RetardLatvia
DuspatalinSerbia
Colospa · Colospa® retard · Rudakol · Rudakol®
© NAPOS 2024